Coherus Biosciences
Coherus Biosciences develops, manufactures and commercializes biologic therapeutics for oncology and inflammatory diseases. Learn more
Launch date
Employees
Market cap
$149m
Enterprise valuation
$259m (Public information from Sep 2024)
Share price
$1.05 CHRS
Redwood City California (HQ)
Authorizing premium user...